Role of mitofusin 2 in the protective effect of breviscapine against hepatic ischemia/reperfusion injury in rats

Bao,Zhen; Chen,Weijun; Pan,Fan; Peng,Bo; Gong,Jin

doi:10.3892/etm.2018.5834

Role of mitofusin 2 in the protective effect of breviscapine against hepatic ischemia/reperfusion injury in rats

Authors:
- Zhen Bao
- Weijun Chen
- Fan Pan
- Bo Peng
- Jin Gong
View Affiliations

Affiliations: Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510630, P.R. China
Published online on: February 5, 2018 https://doi.org/10.3892/etm.2018.5834
Pages: 3582-3588

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The purpose of the present study was to investigate the effect of breviscapine injection on hepatic ischemia/reperfusion (I/R) injury in rats. To explore the relevance and discuss the underlying mechanism of mitofusin 2 (Mfn2) in hepatic I/R injury, 40 Sprague‑Dawley male rats were randomly and equally divided into ﬁve groups (n=8 per group) as follows: Sham, I/R + normal saline 1 (NS1), I/R + breviscapine 1 (Bre1), I/R + NS2 and I/R + Bre2 groups. Groups 1 and 2 represented ischemia for 20 and 60 min, respectively. Breviscapine or normal saline was injected via the tail vein (single dose of 10 mg/kg) 1 h prior to surgery and immediately postoperatively. The classical model of hepatic I/R injury was used in the present study. The blood and liver samples of different groups were collected following reperfusion to observe serum transaminases and histopathological changes. Alterations in Mfn2, cytosolic cytochrome c and cleaved caspase‑3 were additionally assessed. The results demonstrated that breviscapine improved liver function, based on histopathological analysis, and decreased levels of the liver enzymes aspartate and alanine aminotransferase in the I/R + Bre groups compared with the I/R + NS group (P<0.05). The expression of Mfn2 was significantly increased in the I/R + Bre groups (P<0.05), whereas the expression of caspase‑3 and cytosolic cytochrome c protein was decreased in the I/R + Bre groups (P<0.05) compared with the I/R + NS group. These data provided substantial evidence that breviscapine treatment exerted a protective effect against damage induced by hepatic I/R. This protective effect was possibly due to its ability to inhibit I/R‑induced apoptosis and promote the expression of Mfn2.

View Figures

View References

1	Kong R, Gao Y, Sun B, Chen H, Wang G, Wang X, Zhu H, Pan S, Xue D and Jiang H: The strategy of combined ischemia preconditioning and salvianolic acid-B pretreatment to prevent hepatic ischemia-reperfusion injury in rats. Dig Dis Sci. 54:2568–2576. 2009. View Article : Google Scholar : PubMed/NCBI
2	Green DR and Kroemer G: The pathophysiology of mitochondrial cell death. Science. 305:626–629. 2004. View Article : Google Scholar : PubMed/NCBI
3	Brady NR, Hamacher-Brady A and Gottlieb RA: Proapoptotic BCL-2 family members and mitochondrial dysfunction during ischemia/reperfusion injury, a study employing cardiac HL-1 cells and GFP biosensors. Biochim Biophys Acta. 1757:667–678. 2006. View Article : Google Scholar : PubMed/NCBI
4	Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez F, Smith CL and Youle RJ: The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell. 1:515–525. 2001. View Article : Google Scholar : PubMed/NCBI
5	Novgorodov SA and Gudz TI: Ceramide and mitochondria in ischemia/reperfusion. J Cardiovasc Pharmacol. 53:198–208. 2009. View Article : Google Scholar : PubMed/NCBI
6	Zorzano A, Liesa M, Sebastián D, Segalés J and Palacín M: Mitochondrial fusion proteins: Dual regulators of morphology and metabolism. Semin Cell Dev Biol. 21:566–574. 2010. View Article : Google Scholar : PubMed/NCBI
7	Huang P, Galloway C and Yoon Y: Control of mitochondrial morphology through differential interactions of mitochondrial fusion and fission proteins. PLoS One. 6:e206552011. View Article : Google Scholar : PubMed/NCBI
8	Li J, Ke W, Zhou Q, Wu Y, Luo H, Zhou H, Yang B, Guo Y, Zheng Q and Zhang Y: Tumour necrosis factor-α promotes liver ischaemia-reperfusion injury through the PGC-1α/Mfn2 pathway. J Cell Mol Med. 18:1863–1873. 2014. View Article : Google Scholar : PubMed/NCBI
9	Lou XY, Cheng JL and Zhang B: Therapeutic effect and mechanism of breviscapine on cisplatin-induced nephrotoxicity in mice. Asian Pac J Trop Med. 8:873–877. 2015. View Article : Google Scholar : PubMed/NCBI
10	Wang J, Ji SY, Liu SZ, Jing R and Lou WJ: Cardioprotective effect of breviscapine: Inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury. Pharmazie. 70:593–597. 2015.PubMed/NCBI
11	Yiming L, Wei H, Aihua L and Fandian Z: Neuroprotective effects of breviscapine against apoptosis induced by transient focal cerebral ischaemia in rats. J Pharm Pharmacol. 60:349–355. 2008. View Article : Google Scholar : PubMed/NCBI
12	Lin YZ, Lu ZY, Liang XH, Li K, Peng B and Gong J: Effect of breviscapine against hepatic ischemia reperfusion injury. J Surg Res. 203:268–274. 2016. View Article : Google Scholar : PubMed/NCBI
13	Nauta RJ, Tsimoyiannis E, Uribe M, Walsh DB, Miller D and Butterfield A: Oxygen-derived free radicals in hepatic ischemia and reperfusion injury in the rat. Surg Gynecol Obstet. 171:120–125. 1990.PubMed/NCBI
14	Wei Y, Chen P, de Bruyn M, Zhang W, Bremer E and Helfrich W: Carbon monoxide-releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats. BMC Gastroenterol. 10:422010. View Article : Google Scholar : PubMed/NCBI
15	Gomez L, Paillard M, Thibault H, Derumeaux G and Ovize M: Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation. 117:2761–2768. 2008. View Article : Google Scholar : PubMed/NCBI
16	Li H, Sun JJ, Chen GY, Wang WW, Xie ZT, Tang GF and Wei SD: Carnosic acid nanoparticles suppress liver ischemia/reperfusion injury by inhibition of ROS, Caspases and NF-κB signaling pathway in mice. Biomed Pharmacother. 82:237–246. 2016. View Article : Google Scholar : PubMed/NCBI
17	Kamiike W, Fujikawa M, Koseki M, Sumimura J, Miyata M, Kawashima Y, Wada H and Tagawa K: Different patterns of leakage of cytosolic and mitochondrial enzymes. Clin Chim Acta. 185:265–270. 1989. View Article : Google Scholar : PubMed/NCBI
18	Halestrap AP, Clarke SJ and Javadov SA: Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res. 61:372–385. 2004. View Article : Google Scholar : PubMed/NCBI
19	Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, Brunskill EW, Sayen MR, Gottlieb RA, Dorn GW, et al: Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature. 434:658–662. 2005. View Article : Google Scholar : PubMed/NCBI
20	Hüttemann M, Helling S, Sanderson TH, Sinkler C, Samavati L, Mahapatra G, Varughese A, Lu G, Liu J, Ramzan R, et al: Regulation of mitochondrial respiration and apoptosis through cell signaling: Cytochrome c oxidase and cytochrome c in ischemia/reperfusion injury and inflammation. Biochim Biophys Acta. 1817:598–609. 2012. View Article : Google Scholar : PubMed/NCBI
21	Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, Inohara H, Kubo T and Tsujimoto Y: Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature. 434:652–658. 2005. View Article : Google Scholar : PubMed/NCBI
22	Ong SB, Subrayan S, Lim SY, Yellon DM, Davidson SM and Hausenloy DJ: Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation. 121:2012–2022. 2010. View Article : Google Scholar : PubMed/NCBI
23	Kong D, Xu L, Yu Y, Zhu W, Andrews DW, Yoon Y and Kuo TH: Regulation of Ca2+-induced permeability transition by Bcl-2 is antagonized by Drpl and hFis1. Mol Cell Biochem. 272:187–199. 2005. View Article : Google Scholar : PubMed/NCBI
24	Liu X, Feng L, Yan M, Xu K, Yu Y and Zheng X: Changes in mitochondrial dynamics during amyloid β-induced PC12 cell apoptosis. Mol Cell Biochem. 344:277–284. 2010. View Article : Google Scholar : PubMed/NCBI
25	Biel TG, Lee S, Flores-Toro JA, Dean JW, Go KL, Lee MH, Law BK, Law ME, Dunn WA Jr, Zendejas I, et al: Sirtuin 1 suppresses mitochondrial dysfunction of ischemic mouse livers in a mitofusin 2-dependent manner. Cell Death Differ. 23:279–290. 2016. View Article : Google Scholar : PubMed/NCBI
26	Neuspiel M, Zunino R, Gangaraju S, Rippstein P and McBride H: Activated mitofusin 2 signals mitochondrial fusion, interferes with Bax activation, and reduces susceptibility to radical induced depolarization. J Biol Chem. 280:25060–25070. 2005. View Article : Google Scholar : PubMed/NCBI
27	Papanicolaou KN, Khairallah RJ, Ngoh GA, Chikando A, Luptak I, O'Shea KM, Riley DD, Lugus JJ, Colucci WS, Lederer WJ, et al: Mitofusin-2 maintains mitochondrial structure and contributes to stress-induced permeability transition in cardiac myocytes. Mol Cell Biol. 31:1309–1328. 2011. View Article : Google Scholar : PubMed/NCBI